Transfection Technologies Market is anticipated to reach USD 5.1 billion by 2035
The global
market for transfection
technologies market was estimated to be worth USD 2.2 billion in 2024
and is expected to grow at a compound annual growth rate (CAGR) of 12.1% from
2025 to 2035, reaching USD 5.1 billion. In molecular biology, transfection
technologies are essential techniques that enable researchers to control gene
expression and provide new therapies for illnesses and hereditary disorders.
The techniques
used to deliver nucleic acids, like DNA or RNA, into cells for a variety of
scientific and medical applications are known as transfection technologies.
These tools are essential to molecular biology because they enable researchers
to examine how genes work, control how genes are expressed, and create new
treatments for hereditary illnesses.
Request For
Free Sample Pages @ https://www.xresearch.biz/request-sample-pages/transfection-technologies-market
GROWTH
DRIVERS
The need for
novel treatment strategies is fueled by the growing incidence of chronic
illnesses including cancer and heart conditions. In order to develop gene-based
therapeutics that target certain health issues, transfection technologies are
essential. Heart disease, cancer, stroke, diabetes, and chronic renal disease
are among the most common causes of death, according to the NIH.
The emphasis on
genetically customized medicine because transfection techniques allow for
accurate control of cellular functions, facilitating the creation of
individualized treatment plans. The market for transfection technologies is
being driven by the rise in research and development expenditures by government
organizations, academic institutions, and pharmaceutical businesses. For
example, in 2020, Thermo Fisher Scientific, a significant competitor in the
market for transfection technologies, increased its research expenditures by
over $150 million, allocating around $1,181 million to research and
development.
MARKET
SEGMENTATION:
· By
Product– kits, reagents and consumables, instruments and equipment
· By
Transfection Method Type- Physical transfection (electroporation, gene
gun, microinjection, sonication and others), biochemical transfection
(lipofection, cationic lipid transfection, calcium phosphate transfection,
magnet assisted transfection, dendrimer medicated transfection and others) and
viral vector transfection
· By
Application – Biomedical research (cancer research,
transgenic models, gene silencing, gene and protein expression models,
cell-based microarrays), Therapeutic Delivery (biotherapeutics, electro
chemotherapy and immunotherapy), protein production, virus production, stem
cell reprogramming, cell-line generation and others
· By
End-User- Hospitals and clinics, Pharmaceuticals and biotechnology
companies, academic and research institutes, Contract research Organizations
(CROs) and others
· By
Region- North America, Europe, Asia Pacific, The Middle East and
Africa, South America
Global
Key Players:
· Thermo
Fisher Scientific
· Merck
KGaA
· Agilent
Technologies
· Lonza
Group
· Promega
Corporation
· Bio-Rad
Laboratories
· Qiagen
· Altogen
Biosystems
· TAKARA
BIO INC.
· Polyplus-transfection
SA
For More
Information about this Report @ https://www.xresearch.biz/shop/transfection-technologies-market
About Us: -
xResearch is a market research and
consulting organization that uses unique data, expert analysis, and new
technologies to create trusted intelligence on industries. Our research is
focused on delivering an informed and impartial view on essential market data
of industry, and it is primarily driven by an in-depth study covering the
following parameters: Market Sizing and Forecasting, Market Segmentation,
Competitive Analysis, Strategic Assessment and Business Modelling.
Contact:
Company Name: xResearch
Contact Person: James Lin
Email: sales@xresearch.biz
Phone: +1 718-619-8140
Websites: https://www.xresearch.biz/

Comments
Post a Comment